MaxQ AI® ACCIPIO® Software Integrated as Part of GE Healthcare’s Smart Subscription Platform Offering in the U.S. and E.U. Acute Care Markets

Select customers with GE CT scanners can now access and seamlessly integrate MaxQ AI’s revolutionary brain bleed detection software into their workflow via Smart Subscription

Tel Aviv, Israel and Andover, MA – November 27, 2018 – MaxQ AI, a clinical diagnostics intelligence platform company, and GE Healthcare, today announced that MaxQ AI’s ACCIPIO artificial intelligence (AI) platform will now be a part of GE Healthcare’s Computed Tomography (CT) Smart Subscription offering. GE Healthcare’s Smart Subscription provides customers with continuous access to the latest imaging software updates, through an available automatic download to their CT scanners from the cloud. As a Smart Subscription offering, hospitals with GE Healthcare CTs can easily and seamlessly integrate MaxQ AI’s ACCIPIO platform, of which Accipio Ix intracranial hemorrhage (ICH) detection software is now available, to support an acute care physician’s ability to identify and prioritize brain bleed stroke or head trauma.

“Building on our successful collaboration with world-class GE Healthcare, we are pleased that our ACCIPIO intracranial hemorrhage (ICH) detection software has been fully integrated as a function of the Smart Subscription platform,” said Gene Saragnese, CEO of MaxQ AI. “This will also enable hospitals and acute care providers, who are looking to bring the power of our AI-enabled solutions into their emergency rooms, to seamlessly add these new capabilities into the workflow of their existing GE Healthcare CTs, and to standardize these capabilities to future new technology they acquire. A new era of intelligent imaging, combined with the skills of the caregiver, make augmented intelligence available to both the U.S. and European Union customers of GE.”

Focused on the power of digital to enable better outcomes, GE Healthcare’s Smart Subscription is a service that supports the integration and seamless deployment of new innovations such as AI-enabled offerings to keep CT scanners current, reduce variability and bring intelligent imaging into hospitals. Smart Subscription offers flexible options for smarter budgeting, giving health systems, hospitals and clinics the opportunity to standardize applications across all CT units, and select the applications they need, with an option to add or remove applications at any time. With Smart Subscription, customers can be confident that their GE Healthcare CT scanners will be up to date with the latest imaging software for the life of the system.

“The ACCIPIO platform offers deep clinical insight and actionable data in minutes, helping physicians make faster, more accurate assessments of stroke and intracranial hemorrhage,” said Saad Sirohey, General Manager, Global MICT Digital and Clinical Applications for GE Healthcare. “We are proud to offer this technology to our customers as a part of Smart Subscription, an Edison powered service, which provides access to all the latest CT device software – all the time – for one fee per device, per year.”

Accipio Ix, which has received both FDA clearance and CE Mark certification, leverages artificial intelligence technology to automatically analyze non-contrast head CT images. The AI-powered Accipio Ix, part of MaxQ AI ’s unique ACCIPIO INSIGHT™ platform, is designed to be highly sensitive to the presence of ICH, identifying and prioritizing patients with a brain bleed for the treating physician. It provides a capability for rapid escalation and prioritization of the patient and can be natively integrated into CT and PACS systems using the imaging industry-standard DICOM, installed both on-premise and in the future, cloud-capable.

MaxQ AI is demonstrating Accipio Ix – along with the full suite of ACCIPIO platform solutions – during this week’s Radiological Society of North America (RSNA) 2018 Annual Meeting in Chicago (Booth #6161 in the North Hall).

About MaxQ AI

MaxQ AI is at the forefront of transforming healthcare by empowering physicians to provide ‘smarter care’ with artificial intelligence (AI) clinical insights. Based in Tel Aviv, Israel and Andover, MA, our team of deep learning and machine vision experts develop clinical diagnostic intelligent software solutions that enable timely and more accurate diagnosis. Working with world-class clinical and industry partners, we are raising the level of acute care in hospitals around the world to improve patient outcomes and lower costs. To learn more, please visit www.maxq.ai or follow us on Twitter and LinkedIn.

Press Contacts:
For MaxQ AI:
Travis Small
617-538-9041
tsmall@sloweymcmanus.com

Download PDF